New test could identify resistant tuberculosis faster

19-May-2015 - The time needed to genetically sequence the bacteria causing tuberculosis (Mtb) from patient samples has been reduced from weeks to days using a new technique developed by a UCL-led team. This could help health service providers to better treat disease, control transmission of this infection, and ...

Oxford Gene Technology Awarded £1.2m Genomics England Contract

13-Mar-2015 - Oxford Gene Technology (OGT) announced it has been awarded a £1.2m phase two Small Business Research Initiative (SBRI) Healthcare contract. The contract is to develop Next Generation Sequencing (NGS) analysis software, following the successful completion of phase one and an evaluation by Genomics ...

OGT opens New York office and appoints US sales team

22-Nov-2012 - Oxford Gene Technology (OGT) announced that it has opened a new office in Tarrytown, New York to support and grow its cytogenetics arrays and next generation sequencing business in the US.The new office will enable OGT to provide hands-on technical support and training to its existing US ...

OGT founder Professor Sir Ed Southern awarded the 2011 MRC Millennium Medal

Pioneer of DNA microarray technology recognised for outstanding impact in the field of genetic analysis

01-Feb-2012 - Professor Sir Ed Southern, founder of Oxford Gene Technology (OGT) has been awarded the 2011 Medical Research Council (MRC) Millennium Medal. Sir Ed becomes one of only four researchers to have received the prize since it was inaugurated in the year 2000, which recognises an MRC-funded scientist ...

Oxford Gene Technology and Abcodia form Partnership

Companies Combine Expertise to Advance Biomarkers for the Early Diagnosis of Pancreatic Cancer

09-Nov-2011 - Oxford Gene Technology (OGT) has announced a collaborative agreement with Abcodia aimed at improving the early detection of pancreatic cancer. As part of this collaboration, Abcodia will provide access to its large prospective serum biobank, to harness samples taken from individuals up to 7 years ...

OGT to develop tumour profiling assay to facilitate personalised cancer treatment

Company receives £1.16m award from the UK’s Technology Strategy Board

24-Jun-2011 - Oxford Gene Technology (OGT) has announced that it has received a funding award of £1.16 million from the UK government-backed Technology Strategy Board. As part of the project, OGT will develop a tumour profiling assay based on targeted panel enrichment and next generation sequencing (NGS). The ...

OGT Awarded ISO/IEC 17025:2005 Accreditation

17-Feb-2011 - Oxford Gene Technology (OGT) announced that its Genefficiency™ and CytoSure™ array comparative genomic hybridization (aCGH) services have been accredited as meeting ISO/IEC 17025:2005 international standards by the United Kingdom Accreditation Service (UKAS). This new accreditation aligns with ...

OGT Grants DNA Sequence Variation Licence to Biotype Diagnostics GmbH

24-Nov-2010 - Oxford Gene Technology (OGT) and Biotype Diagnostics GmbH announced the completion of a licence agreement granting Biotype access to OGT patents for the detection of DNA sequence variations. The licence, which will remain valid for the lifetime of the patents, provides Biotype with certain rights ...

OGT Presents Promising Prostate Cancer Biomarker Panel Results

Company optimistic about pilot data and embarks on rigorous clinical study

30-Sep-2010 - Oxford Gene Technology (OGT has presented potentially highly significant, preliminary data on the development of a panel of biomarkers for the diagnosis of prostate cancer. In the pilot study, a set of biomarkers was identified which can distinguish prostate cancer from control samples with both ...

OGT Receives ISO/IEC 27001:2005 Accreditation

14-Sep-2010 - Oxford Gene Technology (OGT) announced that it has been certified compliant with ISO/IEC 27001:2005, an international information security management standard. Extending to all data generation and security procedures, including OGT’s CytoSure™ and Genefficiency™ services, biomarker discovery ...